ZyVersa Therapeutics Releases Video Demonstrating How Inflammasomes Stimulate and Perpetuate Inflammation, and How a Novel Inflammasome Inhibitor, IC 100, Has Potential to Control Chronic Damaging Inflammation Associated with Inflammatory Diseases
- Monday, January 20, 2020, 7:16
- PR Newswire
- Add a comment
WESTON, Fla., Jan. 20, 2020 /PRNewswire/ — ZyVersa Therapeutics, Inc., (ZyVersa) a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, is pleased to announce release of a new video demonstrating how…
About the Author
admin has written 21643 stories on this site.